Hospital AI Lab Practical information on medical AI for Singapore hospitals

Updated:

Medical technology and research in Singapore

What is Singapore publishing and testing in medicine right now? This page collects papers whose author affiliations include Singapore and drug trials with sites there, all from the last 12 months, in three groups: surgical techniques, new drugs and therapies, and diseases.

Period: 2025-11-16 to 2026-11-16 · updated automatically every week

How to read this page
  • This is an automatic list of titles, journals, dates and links from PubMed and ClinicalTrials.gov. We do not copy abstracts or article text, and we have not checked the findings.
  • A paper or a trial existing is not evidence that a treatment works or is safe, and it is not medical advice. Ask your clinician about any treatment.
  • “Papers from Singapore” means at least one author affiliation mentions the country; it does not mean the whole study was done there.
  • Titles are shown in their original language (mostly English).

Surgical techniques

Minimally invasive, robot-assisted, endoscopic, joint replacement and transplant papers.

Showing the latest 12 of 479 matches

  1. Regional Variations in Epidemiology, Diagnosis, and Surgical Management of Discoid Meniscus in Pediatric Populations Across Asia-Pacific and North American Regions: A Systematic Review

    Arthrosc Sports Med Rehabil 2026-11-15 Chua CXK, Wang E, Tan CQ et al. PMID 43036512

  2. Two-year functional outcomes of kinematic versus mechanical alignment in primary total knee arthroplasty: a single-surgeon propensity-matched study in an Asian population

    Knee Surg Relat Res 2026-11-13 Neo BXB, Patil VV, Tay KD et al. PMID 43026628

  3. Establishing paediatric robotic surgery in lower-volume centres: an eight-phase implementation roadmap and initial case outcomes

    J Robot Surg 2026-11-13 Lee YY, Nor NHM, Mali VP et al. PMID 43024171

  4. CD8 T cell phenotype diagnoses graft-versus-host disease after liver transplantation

    Am J Transplant 2026-11-11 Song S, Qiu W, Chen Y et al. PMID 43014620

  5. Engineering Reversible Wet Adhesion: Physicochemical Principles from Molecular Interactions to Functional Biointerfaces

    Chem Rev 2026-11-11 Sun H, Deng Z, Yan B et al. PMID 43012489

  6. Preoperative mental health predicts early satisfaction but not two-year knee-specific functional improvement after unicompartmental knee arthroplasty: an analysis of a robotic-assisted cohort

    Arthroplasty 2026-11-11 Ng Y, Lim JTE, Chan I et al. PMID 43010060

  7. Physiological prehabilitation for patients undergoing cellular therapy in multiple myeloma and lymphoma: a systematic review

    Support Care Cancer 2026-11-10 Barredo JMS, Lim CC, Loy Y et al. PMID 43007455

  8. Nitinol continuous-compression staple fixation for selected complex patella fractures: a technical note

    Eur J Orthop Surg Traumatol 2026-11-09 Tan GHC, Yeo KSA PMID 43002280

  9. Comparative Effectiveness of Contemporary Alignment Strategies in Total Knee Arthroplasty: A Systematic Review and Network Meta-Analysis

    J Arthroplasty 2026-11-06 Tan GHC, Lim HA, Thorpe LR et al. PMID 42994644

  10. Kidney stones

    Nat Rev Dis Primers 2026-11-05 Tzelves L, Skolarikos A, Juliebø-Jones P et al. PMID 42988848

  11. Macropolycytes: A Series of 30 Cases

    Pediatr Blood Cancer 2026-11-05 Lee AC PMID 42985877

  12. Significant Differences in the Presentation, Diagnosis, and Management of Juvenile Osteochondritis Dissecans Exist Among Asia-Pacific and European Surgeons

    Arthrosc Sports Med Rehabil 2026-11-04 Hui SJ, Liew JJL, Chew KY et al. PMID 42985630

New drugs and therapies (papers)

Phase 1–3 and randomized trials of drugs, antibodies, vaccines and new therapies.

Showing the latest 12 of 139 matches

  1. Safety, Biodistribution, and Dosimetry of FAP and Integrin α(v)β(3) Dual-Targeting Radioligand (177)Lu-DOTA-FAPI-RGD: Preclinical Validation and First-in-Human Study in Patients with Advanced Adenocarcinomas

    J Nucl Med 2026-11-02 Xiang J, Wen X, Wang R et al. PMID 42624650

  2. A phase 2a, double-blind, randomised, placebo-controlled trial of the myeloperoxidase inhibitor, mitiperstat, in participants with COPD

    Eur Respir J 2026-11-01 Saralaya D, Mustapa MN, Ferreira J et al. PMID 42562590

  3. A Bayesian Re-analysis of the GALFLU Trial of High-Dose vs Standard-Dose Influenza Vaccine Against Hospitalization Outcomes

    Clin Infect Dis 2026-10-28 Pardo-Seco J, Rodriguez-Tenreiro-Sánchez C, Giné-Vázquez I et al. PMID 42546169

  4. First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial

    Lancet 2026-10-26 Slomovitz BM, Zhu J, Yin R et al. PMID 42933458

  5. Ravulizumab in IgA Nephropathy - Interim Analysis of a Phase 3 Trial

    N Engl J Med 2026-10-23 Barratt J, Farag YMK, Rice K et al. PMID 42912700

  6. Determining the minimal important difference of EQ-5D-5 L utility values in CIDP patients using data from a large clinical trial

    Qual Life Res 2026-10-22 Brackx F, Arvin-Berod C, Phillips G et al. PMID 42911306

  7. Inhibition of hIAPP amyloid aggregation by the polyherbal formulation NAMIG-5: a bench-to-bedside translational study

    Biophys Chem 2026-10-02 Nama P, Roy D, Bhunia PK et al. PMID 42854397

  8. Efficacy of immersive virtual reality reminiscence for older persons living in the community in Singapore: A multi-centre study

    Arch Gerontol Geriatr 2026-10-02 Tan KCK, Chia I, Tan K et al. PMID 42849398

  9. Serotype-specific Immunity and Association With Pneumococcal Carriage Following 3+1, 3+0, and 2+1 Schedules of 10-valent Pneumococcal Conjugate Vaccine

    J Infect Dis 2026-09-23 Ong DS, Toh ZQ, Temple B et al. PMID 41818666

  10. Biomarker Analysis from Patients with Metastatic PDAC Treated with TGFβ Antibody NIS793 plus Abraxane + Gemcitabine versus Abraxane + Gemcitabine Alone in a Phase II, Open-Label, Randomized Study

    Clin Cancer Res 2026-09-15 Pelletier M, Yang J, Joshi M et al. PMID 42347868

  11. High-Dose Intravenous Vitamin C and Mortality and Organ Dysfunction in Severe Burn Injury: The VICTORY Randomized Clinical Trial

    JAMA 2026-09-15 Stoppe C, Hill A, Cancio LC et al. PMID 42267875

  12. Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder and Anxious Distress: Post Hoc Analysis of a Phase 3, Randomized, Double-Blind Trial

    J Clin Psychiatry 2026-09-14 Sachs GS, Durgam S, Earley WR et al. PMID 42752587

Drug trials started in the last year

Drug studies registered on ClinicalTrials.gov with a site in this country, newest first.

Showing the latest 12 of 70 matches

  1. Study of MC001 in Patients With Advanced Solid Tumours

    NCT07929961 Phase: Phase 1 Started: 2026-11-16 Sponsor: National University Hospital, Singapore Conditions: Pancreatic Ductal Adenocarcinoma (PDAC), Nasopharyngeal Carcinoma, Advanced Solid Tumours Drug / intervention: MC001

  2. Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

    NCT07521670 Phase: Phase 2 Started: 2026-11-01 Sponsor: National Cancer Centre, Singapore Conditions: Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic, Papillary Thyroid Carcinoma Drug / intervention: Sacituzumab Tirumotecan

  3. Use of Pyrvinium to Reverse Stomach Precancerous Conditions

    NCT06782048 Phase: Phase 2 Started: 2026-11-01 Sponsor: National University Hospital, Singapore Conditions: STOMACH NEOPLASM Drug / intervention: Placebo, Pyrvinium

  4. A Retrospective Study to Assess Patient-Reported Treatment Experience With Over-the-Counter Analgesic Products

    NCT07931859 Started: 2026-11-01 Sponsor: HALEON Conditions: Pain Drug / intervention: Paracetamol

  5. A Study Assessing Eloralintide (LY3841136) in Healthy Participants

    NCT07935304 Phase: Phase 1 Started: 2026-11-01 Sponsor: Eli Lilly and Company Conditions: Healthy Drug / intervention: Eloralintide, Eloralintide

  6. A Study of LY4247147 in Participants With Obesity or Overweight Who Are Otherwise Healthy

    NCT07915245 Phase: Phase 1 Started: 2026-11-01 Sponsor: Eli Lilly and Company Conditions: Obesity, Overweight Drug / intervention: LY4247147, LY4247147

  7. A Study Evaluating the Impact of a Painkiller Product on Quality-of-Life and Daily Functioning

    NCT07909590 Started: 2026-11-01 Sponsor: HALEON Conditions: Pain Drug / intervention: Paracetamol

  8. A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes

    NCT07881887 Phase: Phase 1 Started: 2026-10-01 Sponsor: Eli Lilly and Company Conditions: Obesity, Overweight, Diabetes Mellitus, Type 2 Drug / intervention: LY4167586, Placebo

  9. A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).

    NCT07735637 Phase: Phase 3 Started: 2026-09-24 Sponsor: AstraZeneca Conditions: Newly Diagnosed Multiple Myeloma (NDMM) Drug / intervention: AZD0120, Cyclophosphamide

  10. A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy

    NCT07808073 Phase: Phase 1 Started: 2026-09-22 Sponsor: Eli Lilly and Company Conditions: Obesity, Overweight Drug / intervention: LY4329090, Placebo

  11. A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum

    NCT07811193 Phase: Phase 2 Started: 2026-09-11 Sponsor: Vividion Therapeutics, Inc. Conditions: Colorectal Adenocarcinoma Drug / intervention: VVD-133214, Pembrolizumab

  12. A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

    NCT07623200 Phase: Phase 3 Started: 2026-09-08 Sponsor: Incyte Corporation Conditions: Essential Thrombocythemia Drug / intervention: INCA033989, Best Available Treatment

Diseases and population studies

Nationwide cohorts, registries and population-based studies on incidence and prevalence.

Showing the latest 12 of 1,517 matches

  1. Radiation-induced alopecia: A scoping review

    Tech Innov Patient Support Radiat Oncol 2026-10-24 Leung SSN, Lo AWS, Wong C et al. PMID 43022250

  2. Modelling the transmission and burden of ESBL-producing Enterobacterales from a One Health perspective in Singapore

    One Health 2026-10-23 Xie Y, Graves N, Lim ZZ et al. PMID 42966920

  3. Persistent chemotherapy-induced alopecia: a scoping review

    Curr Opin Support Palliat Care 2026-10-16 Lo AW, Leung SS, Wong CL et al. PMID 42888908

  4. Working-time patterns, job-related well-being, and turnover intentions among paid caregivers: a population-based longitudinal study

    Soc Sci Med 2026-10-10 Li LZ, Xu X PMID 42860080

  5. Elevated wzc mutation frequency promotes carbapenem resistance evolution in hypervirulent Klebsiella pneumoniae ST23

    Emerg Microbes Infect 2026-10-07 Chen T, Wang X, Xiong L et al. PMID 42658964

  6. Risk of abnormal histology following vaginal hysterectomy for pelvic organ prolapse in a multi-ethnic Asian population: a two-year retrospective review

    Eur J Obstet Gynecol Reprod Biol 2026-10-06 Tan YR, Boon ET, Chua HL et al. PMID 42849273

  7. Real-world implementation of ESC guidelines in chronic coronary syndromes: Insights from the EURECA registry with a focus on Italian practice

    Int J Cardiol 2026-09-15 Carrabba N, Guaricci AI, Amico MA et al. PMID 42744020

  8. Machine Learning for Predicting Onset and Progression of Chronic Kidney Disease: A Scoping Review

    Kidney Med 2026-09-04 Sabanayagam C, Koh BMQR, Thyagarajan P et al. PMID 43022373

  9. The Ergonomics of Endoscopic Ear Surgery: An International Survey

    Otol Neurotol 2026-08-24 Lin J, Lee JJ, Saxby AJ et al. PMID 42635414

  10. Tuberculosis disease and infection among household contacts of bacteriologically confirmed vs unconfirmed tuberculosis in Cambodia: considerations for optimising contact investigation and preventive treatment

    Ann Med 2026-08-19 Tep S, Tuot S, Cheng S et al. PMID 42615857

  11. Variations in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Phenotypes and Treatment Outcomes Across Singaporean, Canadian Asian, and Canadian Caucasian Populations

    Am J Ophthalmol 2026-08-14 Huang A, Ling J, Gilead N et al. PMID 42600888

  12. AI Writing Vocabulary in Ophthalmology: Faster Non-Native Adoption, Unchanged Outcomes

    Am J Ophthalmol 2026-08-12 Berni A, Ting DSW, Caputo G et al. PMID 42586190

Source: PubMed · ClinicalTrials.gov